Serum myostatin is reduced in individuals with metabolic syndrome.
Myostatin is a negative regulator of skeletal muscle mass and may also modulate energy metabolism secondarily. We aim to investigate the relationship between serum myostatin and the metabolic variables in diabetic (DM) and non-diabetic subjects.A cross-sectional study recruiting 246 consecutive DM p...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4177900?pdf=render |
id |
doaj-9b18b6073b854ba29ef46038a3ff179a |
---|---|
record_format |
Article |
spelling |
doaj-9b18b6073b854ba29ef46038a3ff179a2020-11-24T21:50:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0199e10823010.1371/journal.pone.0108230Serum myostatin is reduced in individuals with metabolic syndrome.Der-Sheng HanYu Chu-SuChih-Kang ChiangFen-Yu TsengPing-Huei TsengChi-Ling ChenKwan-Dun WuWei-Shiung YangMyostatin is a negative regulator of skeletal muscle mass and may also modulate energy metabolism secondarily. We aim to investigate the relationship between serum myostatin and the metabolic variables in diabetic (DM) and non-diabetic subjects.A cross-sectional study recruiting 246 consecutive DM patients and 82 age- and gender-matched non-diabetic individuals at a medical center was conducted. The variables of anthropometry and blood chemistry were obtained. Serum myostatin level was measured with enzyme immunoassay.DM group had lower serum myostatin compared with non-diabetics (7.82 versus 9.28 ng/ml, p<0.01). Sixty-two percent of the recruited individuals had metabolic syndrome (MetS). The patients with MetS had significantly lower serum myostatin than those without (7.39 versus 9.49 ng/ml, p<0.001). The serum myostatin level decreased with increasing numbers of the MetS components (p for trend<0.001). The patients with higher body mass index, larger abdominal girth, lower high-density lipoprotein cholesterol (HDL-C), and higher triglycerides had lower serum myostatin than those without. The serum myostatin level was independently negatively related to larger abdominal girth, higher triglycerides, and lower HDL-C after adjustment. The odds ratios for MetS, central obesity, low HDL-C, high triglycerides, and DM were 0.85, 0.88, 0.89, 0.85, and 0.92, respectively, when serum myostatin increased per 1 ng/mL, in the binary logistic regression models.Lower serum myostatin independently associated with MetS, central obesity, low HDL-C, and high triglycerides after adjustment. Higher serum myostatin is associated with favorable metabolic profiles.http://europepmc.org/articles/PMC4177900?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Der-Sheng Han Yu Chu-Su Chih-Kang Chiang Fen-Yu Tseng Ping-Huei Tseng Chi-Ling Chen Kwan-Dun Wu Wei-Shiung Yang |
spellingShingle |
Der-Sheng Han Yu Chu-Su Chih-Kang Chiang Fen-Yu Tseng Ping-Huei Tseng Chi-Ling Chen Kwan-Dun Wu Wei-Shiung Yang Serum myostatin is reduced in individuals with metabolic syndrome. PLoS ONE |
author_facet |
Der-Sheng Han Yu Chu-Su Chih-Kang Chiang Fen-Yu Tseng Ping-Huei Tseng Chi-Ling Chen Kwan-Dun Wu Wei-Shiung Yang |
author_sort |
Der-Sheng Han |
title |
Serum myostatin is reduced in individuals with metabolic syndrome. |
title_short |
Serum myostatin is reduced in individuals with metabolic syndrome. |
title_full |
Serum myostatin is reduced in individuals with metabolic syndrome. |
title_fullStr |
Serum myostatin is reduced in individuals with metabolic syndrome. |
title_full_unstemmed |
Serum myostatin is reduced in individuals with metabolic syndrome. |
title_sort |
serum myostatin is reduced in individuals with metabolic syndrome. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
Myostatin is a negative regulator of skeletal muscle mass and may also modulate energy metabolism secondarily. We aim to investigate the relationship between serum myostatin and the metabolic variables in diabetic (DM) and non-diabetic subjects.A cross-sectional study recruiting 246 consecutive DM patients and 82 age- and gender-matched non-diabetic individuals at a medical center was conducted. The variables of anthropometry and blood chemistry were obtained. Serum myostatin level was measured with enzyme immunoassay.DM group had lower serum myostatin compared with non-diabetics (7.82 versus 9.28 ng/ml, p<0.01). Sixty-two percent of the recruited individuals had metabolic syndrome (MetS). The patients with MetS had significantly lower serum myostatin than those without (7.39 versus 9.49 ng/ml, p<0.001). The serum myostatin level decreased with increasing numbers of the MetS components (p for trend<0.001). The patients with higher body mass index, larger abdominal girth, lower high-density lipoprotein cholesterol (HDL-C), and higher triglycerides had lower serum myostatin than those without. The serum myostatin level was independently negatively related to larger abdominal girth, higher triglycerides, and lower HDL-C after adjustment. The odds ratios for MetS, central obesity, low HDL-C, high triglycerides, and DM were 0.85, 0.88, 0.89, 0.85, and 0.92, respectively, when serum myostatin increased per 1 ng/mL, in the binary logistic regression models.Lower serum myostatin independently associated with MetS, central obesity, low HDL-C, and high triglycerides after adjustment. Higher serum myostatin is associated with favorable metabolic profiles. |
url |
http://europepmc.org/articles/PMC4177900?pdf=render |
work_keys_str_mv |
AT dershenghan serummyostatinisreducedinindividualswithmetabolicsyndrome AT yuchusu serummyostatinisreducedinindividualswithmetabolicsyndrome AT chihkangchiang serummyostatinisreducedinindividualswithmetabolicsyndrome AT fenyutseng serummyostatinisreducedinindividualswithmetabolicsyndrome AT pinghueitseng serummyostatinisreducedinindividualswithmetabolicsyndrome AT chilingchen serummyostatinisreducedinindividualswithmetabolicsyndrome AT kwandunwu serummyostatinisreducedinindividualswithmetabolicsyndrome AT weishiungyang serummyostatinisreducedinindividualswithmetabolicsyndrome |
_version_ |
1725882799293988864 |